Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$7.48 - $10.7 $20.4 Million - $29.2 Million
2,727,500 New
2,727,500 $27.8 Million
Q1 2022

May 18, 2022

SELL
$7.33 - $9.39 $696,350 - $892,050
-95,000 Reduced 95.0%
5,000 $47,000
Q4 2020

Feb 16, 2021

BUY
$8.61 - $11.04 $628,530 - $805,919
73,000 Added 270.37%
100,000 $960,000
Q2 2018

Aug 14, 2018

SELL
$16.77 - $24.71 $5.25 Million - $7.73 Million
-313,000 Reduced 92.06%
27,000 $512,000
Q3 2017

Nov 14, 2017

BUY
$15.41 - $32.17 $5.24 Million - $10.9 Million
340,000
340,000 $5.98 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Nomura Holdings Inc Portfolio

Follow Nomura Holdings Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.